GCTK
Glucotrack, Inc.
Key Financials
Operating Income
$-16090000
↓ 10.6%
Revenue
$208762
↑ 0.4%
Net Income
$-19388000
↑ 14.2%
Total Assets
$7.8M
↑ 32.1%
Total Liabilities
$5.0M
↓ 73.5%
Shareholders' Equity
$2.8M
↑ 121.8%
EPS (Diluted)
$31.22
↓ 54.4%
Cash & Equivalents
$7.4M
↑ 31.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| PRE 14A | 6/17/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| EFFECT | 4/30/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| POS AM | 4/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GCTK |
| Company Name | Glucotrack, Inc. |
| CIK | 1506983 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 972 (8) 675-7878 |